Michael McCully

Michael McCully serves as Executive Vice President, Chief Financial and Business Officer of Charleston Laboratories, Inc.  Mr. McCully established his career in the biotech industry in the early 2000’s as an analyst and pundit at the advisory firm Recombinant Capital, Inc.  A frequent and noted speaker on industry meta-trends, Mr. McCully specialized in both the structuring and valuation of biotech and pharmaceutical strategic transactions.  In 2008, Recombinant Capital merged with Deloitte, and Mr. McCully assumed a role in Deloitte’s Life Sciences Practice, based in San Francisco.  Mr. McCully advised hundreds of biotech and pharmaceutical companies during his years with Recombinant Capital and Deloitte, successfully leading teams through both buy-side and sell-side transactions, culminating with more than 40 completed transactions with an aggregate value in excess of $6 billion.  Since leaving Deloitte in 2010, Mr. McCully has held senior advisory roles for multiple public and private biotechnology companies, as well as serving as Head of Business Development for Elan Pharmaceuticals BioNeurology unit.  Prior to his transition to industry, Mr. McCully was a Research Associate at Purdue University.  He holds a BS from Purdue University and a hybrid MS from Northwestern University.